Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03011307 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT03011307 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 126 participants.
The verdict
NCT03011307, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of intrathecal oxytocin on speed of reduction in pain for the first 60 days after hip surgery.
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-01-12 |
| Est. Completion | 2021-08-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03011307
The ClinicalTrials.gov registry entry for NCT03011307 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03011307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03011307 about?
NCT03011307 is a clinical study titled "Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery". The purpose of this study is to determine the effect of intrathecal oxytocin on speed of reduction in pain for the first 60 days after hip surgery.
What is the current status of trial NCT03011307?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2017-01-12. Estimated completion is 2021-08-11.
What interventions are being tested in trial NCT03011307?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03011307?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.